U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06881550) titled 'Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer Surgery' on March 12.
Brief Summary: This study aims to explore the clinical efficacy of Shenbailing granules in improving quality of life and reducing cancer-related fatigue in a real-world setting, with the goal of providing clinical evidence for the use of Shenbailing granules in alleviating cancer-related fatigue among post-breast cancer surgery patients.
Study Start Date: Dec. 30, 2024
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Intervention:
DRUG: Shenbailing
Adjuvant therapy with Shenbailing granules,...